• This clearance marks a significant advancement in glaucoma care, especially for earlier stages of the disease and across a wide spectrum of glaucoma types.
• This novel, proprietary laser-based system features a unique mechanism of action.
• Designed to deliver vibrant, high-quality visualization of eye anatomy.
• Broad commercialization is planned for 2025.

WALTHAM, Mass., April 17, 2025 (GLOBE NEWSWIRE) – BVI Medical, a leading global ophthalmic device company dedicated to sitting at the forefront of advancements in eye surgery, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its innovative glaucoma surgical system, Leos™ (Laser Endoscopy Ophthalmic System) Read More

• Positions company for several new product launches and scaling of operations to meet rising demand globally

• $1 billion of new capital raised to refinance debt and fund accelerated growth

Waltham, MA, March 10th, 2025 – BVI Medical, a leading global ophthalmic device company dedicated to sitting at the forefront of advancements in eye surgery, today announced the completion of a $1 billion strategic capital raise in partnership with TPG, a leading global alternative asset management firm. This investment, which fully refinances BVI’s existing debt and adds new equity from both TPG and new investors, strengthens the company’s financial position as it looks to accelerate product innovation and expand its global footprint. Read More

• EyeXchange Solutions connects experienced and emerging surgeons across cataract, glaucoma, and retina specialties to share insights, refine techniques, and address complex cases.

• BVI Medical aims to facilitate a collaborative forum fostering learning in ophthalmology through video series, engaging email discussions, and interactive quizzes.

Waltham, MA, January 31st, 2024 - BVI Medical, a diversified global ophthalmic device company committed to advancing eye surgery and improving patients’ vision, is excited to introduce EyeXchange Solutions. This new platform is designed to advance vision care through a comprehensive program of educational resources and clinical support, empowering surgical decisions, enhancing provider experiences, reducing the economic burden on healthcare systems, and optimizing patient care in cataract, glaucoma, and retina specialties. Read More

• BVI continues to grow and build a strong company culture based on simplicity, transparency and an entrepreneurial mindset.
• BVI opens an office in Krakow (Poland), welcoming over 50 employees

Waltham, MA, September 16th, 2024 – BVI, one of the fastest-growing, diversified companies in ophthalmology, is proud to announce the creation of its new BVI Poland entity, opening a new office in Krakow. This September, BVI celebrated the grand opening for local employees, their leaders, and members of the Leadership Team. Read More

BVI to Launch New SERENITY and SERENITY Toric Premium Monofocal IOLs, Delivering an Extended Range of Vision to More Patients, at the 2024 ESCRS Read More